Protein-based masks to unlock conditional activation of therapeutics
Molecular Therapy · 2026-11 · 34 (11) · 6202-6218
DOI: 10.1016/j.ymthe.2026.08.047 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Therapy, 2026-11. Verfasst von Nithya M Badarinath und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, 311 Ferst Drive NW, Ford Environmental Science & Technology Buildin…. Hauptthemen laut MEDLINE: Proteins. Die Arbeit nennt 146 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, Advanced Research Projects Agency for Health.
Abstract (Originalsprache)
Protein therapeutic binders provide targeted treatment options for autoimmune, cardiovascular, and neurodegenerative diseases, as well as cancer. However, these therapies can cause off-site toxicities when they bind to healthy tissue that also expresses their target. One method to combat this issue is through the addition of a masking moiety that prevents binding until released by a particular stimulus. Both protein- and peptide-derived masks can inhibit binding, either via steric hindrance using large domains or by affinity-based direct competition. In diseased tissue, protease expression levels and pH are often altered, which can be leveraged for site-specific removal or deactivation of a masking moiety. Therefore, emergent strategies have been used to design conditionally activated, disease-targeted, protein-based therapeutics. This review will focus on the design, effectiveness, and mechanism of masks for cytokines, antibodies, and their derivatives and further discuss strategies for future therapeutic avenues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, 311 Ferst Drive NW, Ford Environmental Science & Technology Building, Atlanta, GA 30332, USA; Bioengineering Program, Georgia Institute o…
Förderung
- NCI NIH HHS
- Advanced Research Projects Agency for Health
Zitieren
APA
Badarinath, N. M., & Blazeck, J. (2026). Protein-based masks to unlock conditional activation of therapeutics. Molecular Therapy, 34(11), 6202-6218. https://doi.org/10.1016/j.ymthe.2026.08.047
Vancouver
Badarinath NM, Blazeck J. Protein-based masks to unlock conditional activation of therapeutics. Molecular Therapy. 2026;34(11):6202-6218. doi:10.1016/j.ymthe.2026.08.047
BibTeX
@article{Badarinath2026,
author = {Badarinath, Nithya M and Blazeck, John},
title = {Protein-based masks to unlock conditional activation of therapeutics},
journal = {Molecular Therapy},
year = {2026},
volume = {34},
number = {11},
pages = {6202--6218},
doi = {10.1016/j.ymthe.2026.08.047}
}
EUVIMED